BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curson, D. A.
Right arrow Articles by Duffy, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curson, D. A.
Right arrow Articles by Duffy, J. C.

The British Journal of Psychiatry 146: 464-469 (1985)
© 1985 The Royal College of Psychiatrists

Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic

DA Curson, TR Barnes, RW Bamber, SD Platt, SR Hirsch and JC Duffy

A follow-up study of all patients entering the MRC double-blind trial of fluphenazine decanoate in chronic schizophrenic out-patients achieved a trace rate of 94%. In general, these patients were severely disabled, continued under the care of the maintenance clinic, and their diagnoses remained remarkably consistent; more than one-fifth were found to be in acute schizophrenic relapse and in over a half of these cases, the relapse was not known to the treatment agency. The maintenance clinic attenders were little different from those who no longer used such a facility.


This article has been cited by other articles:


Home page
 Schizophr BullHome page
J. R Bola
Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?
Schizophr Bull, April 1, 2006; 32(2): 288 - 296.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
M. Valenstein, K. L. Barry, F. C. Blow, L. Copeland, and E. Ullman
Agreement Between Seriously Mentally Ill Veterans and Their Clinicians About Medication Compliance
Psychiatr Serv, August 1, 1998; 49(8): 1043 - 1048.
[Abstract] [Full Text]

Home page
 BMJHome page
N. Tarrier, L. Yusupoff, C. Kinney, E. McCarthy, A. Gledhill, G. Haddock, and J. Morris
Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia
BMJ, August 1, 1998; 317(7154): 303 - 307.
[Abstract] [Full Text]

Home page
 Hispanic Journal of Behavioral SciencesHome page
H. M. Hosch, G. A. Barrientos, C. Fierro, J. I. Ramirez, M. P. Pelaez, A. M. Cedillos, L. D. Meyer, and Y. Perez
Predicting Adherence to Medications by Hispanics with Schizophrenia
Hispanic Journal of Behavioral Sciences, August 1, 1995; 17(3): 320 - 333.
[Abstract]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1985 The Royal College of Psychiatrists.